Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists

CONCLUSION: Orally administered activated factor X inhibitors carried a similar risk of bleeding and death when compared with VKAs in patients with NVAF undergoing chronic hemodialysis. Moreover, there was a trend towards a reduction of thromboembolic events or stroke in patients receiving DOACs.PMID:38404942 | PMC:PMC10885786 | DOI:10.1016/j.rpth.2024.102332
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Source Type: research